This case ensue GlaxoSmithKline (A), 514049 and GlaxoSmithKline (B), 514050. Four of the GlaxoSmithKline workforce were indicted of bribing Chinese health care human resources to advise the company's drugs.
The allegation brought to light the doubtful incentive structures of the Chinese health care system and the anxiety on corporation to adhere to local traditions while still observing local laws.
PUBLICATION DATE: January 16, 2014 PRODUCT #: 514092-PDF-ENG
This is just an excerpt. This case is about SALES & MARKETING
Related Case Solutions & Analyses:
WE Marketing Group: Building a Global Marketing and Communication Company in China
Strategic Analysis of Cemex
BMW-MINI
Marketing McDonald’s in India
Expedia Incorporation
Fresno’s Social Impact Bond for Asthma
Oligopoly Market Price Elasticity of Demand
International Marketing Plan
A123 Systems Powering a Sustainable Future: Strategizing in the Advanced Battery Market
Why CRM Fails-and How to Fix It
